| ADR | Adverse Drug Reaction |
| CAP | College of American Pathologists |
| CLIA | Clinical Laboratory Improvement Amendments |
| CPIC | Clinical Pharmacogenetics Implementation Consortium |
| CPND | Canadian Pharmacogenomics Network for Drug Safety |
| DPWG | Dutch Pharmacogenetics Working Group |
| DTC-GT | Direct-to-Consumer Genetic Test |
| DTC-PT | Direct-to-Consumer Pharmacogenomic Test |
| ESHG | European Society of Human Genetics |
| FGVs | Functional Genetic Variations |
| GA4GH | Global Alliance for Genomics and Health |
| HGP | Human Genome Project |
| IF | Incidental Finding |
| IVD | In Vitro Diagnostic |
| NGS | Next-Generation Sequencing |
| NCB | Nuffield Council on Bioethics |
| PGx | Pharmacogenomics |
| PPM | Personalized and Precision Medicine |
| SNP | Single Nucleotide Polymorphism |
| SSS | Scientific Support Section |
| VUS | Variants of Unknown Significance |
| WES | Whole Exome Sequencing |
| WGS | Whole Genome Sequencing |